TP-6076

DRUG2 trials

Sponsors

Tetraphase Pharmaceuticals, Inc, Tetraphase Pharmaceuticals, Inc.

Conditions

Healthy SubjectsInfecties. Infections.

Phase 1

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

CompletedNCT03691584

Tetraphase Pharmaceuticals, IncHealthy Subjects

Start: 2018-11-26End: 2019-12-18Updated: 2021-12-17

Unknown Phase

A phase 1, randomized, placebo-controlled study to assess the safety and pharmacokinetics of multiple ascending dose regimens of TP-6076.

Active, not recruitingNL-OMON45496

Tetraphase Pharmaceuticals, Inc.Infecties. Infections.

Start: 2017-03-29Target: 56Updated: 2024-02-28